The structure of hepatitis B virus (HBV) nucleocapsids has been revealed in great detail by cryoelectron microscopy. How nucleocapsids interact with surface antigens to form enveloped virions remains unknown. In this study, core mutants with N-terminal additions were created to address two questions : (1) can these mutant core proteins still form nucleocapsids and (2) if so, can the mutant nucleocapsids interact with surface antigens to form virion-like particles. One plasmid encoding an extra stretch of 23 aa, including six histidine residues, fused to the N terminus of the core protein (designated HisC183) was expressed in Escherichia coli and detected by Western blot. CsCl gradient and electron microscopy analyses indicated that HisC183 could self-assemble into nucleocapsids. When HisC183 or another similar N-terminal fusion core protein (designated FlagC183) was co-expressed with a core-negative plasmid in human hepatoma cells, both mutant core proteins self-assembled into nucleocapsids. These particles also retained kinase activity. Using an endogenous polymerase assay, a fill-in HBV DNA labelled with isotope was obtained from intracellular nucleocapsids formed by mutant cores. In contrast, no such signal was detected from the transfection medium, which was consistent with PCR and Southern blot analyses. Results indicate that core mutants with N-terminal extensions can form nucleocapsids, but are blocked during the envelopment process and cannot form secreted virions. The mutant nucleocapsids generated from this work should facilitate further study on how nucleocapsids interact with surface antigens.
Introduction
Human hepatitis B virus (HBV) has been a focus of clinical and basic studies due to its infection being a worldwide health problem and its unique structure and life-cycle among animal DNA viruses (Szmuness, 1978 ; Beasley et al., 1981 ; Tiollais et al., 1981 ; Ganem & Varmus, 1987) . HBV DNA is partially double-stranded and about 3n2 kb long. Although its genome is DNA, it replicates through an RNA intermediate (Summers & Mason, 1982) , the so-called ' pregenomic RNA'. The pregenomic RNA (pregenome) and viral polymerase, together with cellular kinase and heat shock proteins, are encapsidated by viral core proteins, which have 183 or 185 aa residues depending on sero-subtypes, to form nucleocapsids (Nassal & Schaller, 1993 ; Kann & Gerlich, 1994 ; Nassal, 1996 ; Hu & Seeger, 1997 ; Kau & Ting, 1998) . Inside the nucleocapsids, the Author for correspondence : Szecheng J. Lo.
Fax j886 2 2821 2880. e-mail losj!ym.edu.tw first strand of DNA is synthesized by reverse transcription (see review by Nassal, 1996) . Thereafter, nucleocapsids interact with viral surface antigens that are embedded in a lipid bilayer of endoplasmic reticulum (ER) and bud into the ER lumen to form mature virions, termed Dane particles (Bruss & Ganem, 1991 ; Huovila et al., 1992 ; Wei et al., 1996) . Recently, the interaction domains of capsid proteins and surface antigens were characterized and mapped (Dyson & Murray, 1995 ; Poisson et al., 1997 ; Bruss, 1997) . However, the interaction mechanism between nucleocapsid proteins and surface antigens remains poorly understood.
A model of the three-dimensional structure of HBV nucleocapsid has been revealed to a resolution of 35n0-7n4 A / by cryoelectron microscopy (Crowther et al., 1994 ; Conway et al., 1997 Conway et al., , 1998 Zlotnick et al., 1996 Zlotnick et al., , 1997 Bottcher et al., 1997 Bottcher et al., , 1998 . The proposed models agree that three regions of core protein, aa 78-82, 127-130 and 145-153 , are exposed on the shell of nucleocapsids. Neither the N nor the C terminus of the core protein is on the external surface. The N-terminal portion (aa 1-150) of core protein is capable of self-assembling into nucleocapsids even in the absence of the C terminus (Birnbaum & Nassal, 1990 ; Nassal, 1992 ; Halton et al., 1992) . In contrast, core mutants bearing a small insertion, substitution or deletion in the N-terminal domain of HBV core protein (Beames & Lanford, 1995 ; Metzger & Bringas, 1998 ; Konig et al., 1998) or woodchuck hepatitis virus (WHV) core protein (Yu et al., 1996) fail to form nucleocapsids. However, studies on duck HBV show that the core protein N-terminal additions have various effects on capsid formation depending on the nature of the extension peptides (von Weizsacker et al., 1996 ; Kock et al., 1998) . Therefore, the influence of the core protein N terminus on nucleocapsid assembly needs to be further investigated. Conway et al. (1998 b) used an extraneous octapeptide to demonstrate that the core protein N terminus is localized at the spike near the entrance of the shell. In this study, we constructed and expressed N-terminal extension core proteins which were either rich in a positive charge of histidine (designated HisC183) or rich in a negative charge of glutamic acid (designated FlagC183) to test their effect on nucleocapsid assembly in either a prokaryotic or a eukaryotic system. We also tested similar constructs for their influence on virion formation by trans-supplementing a core-negative HBV clone in HuH-7 hepatoma cells. We have demonstrated that the Nterminal extension of core proteins does not interfere with core protein dimerization (Zheng et al., 1992 ; and nucleocapsid assembly. Since protein kinase activity has been demonstrated in the HBV nucleocapsid (Albin & Robinson, 1980 ; Gerlich et al., 1982) , in which the serine residues located at the C terminus of core protein are the substrate of the HBV-associated kinase (Roossinck & Siddiqui, 1987 ; Yeh & Ou, 1991) , we have also shown that the Nterminal core mutants do not interfere with kinase encapsidation. However, the result of blocking nucleocapsids from envelopment by surface antigens supported the hypothesis that the N terminus of the core protein is localized near the surface of the capsid shell.
Methods
Plasmids and construction of mutants. Standard techniques were used for DNA manipulation (Sambrook et al., 1989) . Plasmids pMH 3\3097 (Junker et al., 1987) and pMH 3\3097mC (Lin & Lo, 1992) were used as described previously. pHisC183 ( Fig. 1 a, line 2 ) is a prokaryotic expression plasmid which encodes an N-terminal His-tagged core protein.
The vector pET-15b (Novagen), containing a His-tag, was cleaved with XhoI (filled-in) and BamHI and then ligated with the 1 kb NcoI (filledin)\BamHI fragment from pMH 3\3097mC to generate pHisC183. pHBVHisC183 ( Fig. 1 a, line 3 ) is a eukaryotic expression plasmid which, like pHisC183, encodes an N-terminal His-tagged core protein. The NcoI\EcoRI fragment of pHisC183, containing the His-tag fused C gene, was ligated with the EcoRI\NcoI-digested pMH 3\3097mC to give pHBVHisC183. pHBVFlagC183 (Fig. 1 a, line 4 ) is another eukaryotic expression plasmid which encodes an N-terminal Flag-tagged core protein and was obtained from the insertion of NcoI (filled-in)\BamHI fragment from pMH 3\3097mC into the HindIII (filled-in) and BamHI sites of pFLAG-CMV2 vector (Eastman Kodak). The junctions of newly created plasmids were ascertained by the dideoxy termination method of DNA sequencing (Sanger et al., 1977) . All plasmids used in this study are shown in Fig. 1 (a) and the characteristics of the N-terminal extensions of the core protein are listed in Fig. 1 
(b).
Core protein expression in Escherichia coli. E. coli strains BL21(DE3) or JM109(DE3) harbouring various plasmids were grown to an OD '!! of 1n0 in 800 ml LB medium containing 50 µg\ml ampicillin, followed by the addition of 1 mM IPTG ; the culture was then shaken at 37 mC for another 3 h. Bacteria were lysed in a French press (800 psi) and the cellular debris was removed by centrifugation at 18 000 g for 15 min. The supernatant was collected and passed through a 0n45 µm filter.
Purification of core protein. E. coli lysates from the 800 ml culture described above were incubated with Ni# + -chelated His $ Bind resin (Novagen) in binding buffer (20 mM Tris-HCl, pH 7n9, 0n5 M NaCl and 5 mM imidazole) at room temperature for 1 h. After three washes with binding buffer and washing buffer (20 mM Tris-HCl, pH 7n9, 0n5 M NaCl and 60 mM imidazole), the proteins were eluted with elute buffer (20 mM Tris-HCl, pH 7n9, 0n5 M NaCl and 1 M imidazole) at room temperature for 30 min. The eluate (5 ml) was collected (concentration 0n17 mg\ml) and aliquots (10 µl) were run on 15 % SDS-PAGE (Laemmli, 1970) and stained with Coomassie brilliant blue for analysis of protein purity.
CsCl gradient centrifugation. E. coli lysates or nucleocapsids from media or cell lysate (see below) were resuspended in a high-salt TNE buffer (10 mM Tris-HCl, pH 7n4, 150 mM NaCl, 1 mM EDTA and 0n1% sodium azide) and subjected to CsCl centrifugation (average density 1n24 g\ml) at 35 000 r.p.m. in an SW41 rotor for 44 h. The gradients (final density 1n1-1n5 g\ml) were fractionated into 0n5 ml samples from the top to bottom and each fraction was subjected to ELISA for detection of core antigen and\or surface antigen (General Biologicals). The density of individual fractions was determined by the refractive index using a refractometer.
Electron microscopy. Core particles prepared from Ni# + -chelated His $ Bind resin and CsCl fractions were collected and spotted onto Formvar-coated grids, then negatively stained with saturated uranyl acetate and visualized in a JEOL JEM-2000ExII transmission electron microscope as described previously (Chang et al., 1987) .
Cell culture and transfection. Human hepatoma cells (HuH-7) were grown in Dulbecco's modified Eagle's medium supplemented with 10 % foetal bovine serum, 1 mM glutamine, 10 U\ml penicillin and 100 µg\ml streptomycin. HuH-7 cells were transfected with an appropriate amount of plasmid, either singly or in combinations, using the calcium phosphate co-precipitation procedure (Graham & van der Eb, 1973 ; Sambrook et al., 1989) . At 3, 6 and 9 days post-transfection, media were harvested for viral particle analysis. At 9 days post-transfection, cells were harvested for analysis of nucleocapsid and viral DNA.
Viral nucleocapsid isolation.
To collect nucleocapsids from intracellular extracts, transfected cells were detached from plates and incubated in PBS with 1 % NP-40 at 4 mC overnight (Beames & Lanford, 1995) . After a low-speed centrifugation to remove nuclei and NP-40-insoluble cell debris, the cellular lysate was ready for a further isolation step. To collect nucleocapsids and virion-like particles from culture fluids, the media were incubated with or without detergent (NP-40 to a final concentration of 1 %) at room temperature for 2 h before centrifugation. Both samples were clarified by centrifugation at 13 000 r.p.m. for 30 min in a JA-20 rotor (Beckman Instruments). The nucleocapsids were then concentrated by further centrifugation at 45 000 r.p.m. in a Ti55.2 rotor for 2n5 h while the Dane-like particles were enriched under the same conditions for 5 h. The isolated viral particles were subsequently resuspended in a low-salt TNE buffer (10 mM Tris-HCl, pH 7n5, 100 mM NaCl and 1 mM EDTA).
Immunoprecipitation and Western blotting analysis. The precleared cell lysate was incubated with primary antibodies bound with Sepharose-protein A or G. Antibodies of rabbit polyclonal anti-core (Dako), mouse monoclonal anti-6iHis (Clontech) and anti-Flag (Kodak) were used. The antigen-antibody complexes were precipitated and washed three times with NET buffer (50 mM Tris, pH 7n5, 150 mM NaCl, 0n5 mM EDTA and 0n5 % NP-40) and then boiled in sample buffer (Laemmli, 1970) and analysed by 15 % SDS-PAGE under reducing (with DTT) or non-reducing (without DTT) conditions. Western blotting was performed by reacting with anti-core, anti-6iHis or anti-Flag antibodies following by reacting with secondary antibodies, conjugated with horseradish peroxidase (Organ Teknika). The blot was developed with an enhanced chemiluminescence (ECL) detection system (Amersham Pharmacia).
In vitro kinase assay. The immunoprecipitated nucleocapsids were washed three times and then incubated in a kinase reaction buffer (50 mM Tris-HCl, pH 7n4, 10 mM MgCl # and 0n4 % NP-40) containing 10 pmol [γ-$#P]ATP (7000 Ci\mmol ; Amersham) as described previously (Jeng et al., 1991 ; Lin & Lo, 1992) . After incubation at 37 mC for 1 h, the complex was washed five times with NET buffer and then subjected to 15 % SDS-PAGE separation and autoradiographed.
Endogenous DNA polymerase assay. Endogenous DNA polymerase activity was assayed as described previously (Junker et al., 1987) with some modification (Chiang et al., 1990 ; Lin & Lo, 1992) . Briefly, onefifth of the partially purified viral particle samples was incubated with a pol-mix buffer (50 mM Tris-HCl pH 7n4, 40 mM NH % Cl, 5 mM MgCl # , 0n5 % NP-40, 0n2 % 2-mercaptoethanol and 25 µM each of dATP, dGTP and dTTP) at 37 mC for 2 h in the presence of [α-$#P]dCTP (5000 mCi\ mmol ; Amersham). Subsequently, a chase was performed for 2 h by adding unlabelled dCTP (25 µM final concentration) at 37 mC. Unwanted nucleic acids present outside of particles were digested by micrococcal nuclease (5 U) for 1 h at 37 mC. Particles were then digested by 50 µg\ml proteinase K treatment in the presence of 1 % SDS for 1 h at 37 mC. Glycogen was added (0n8 mg\ml final concentration) and samples were extracted with an equal volume of phenol\chloroform. The labelled DNAs were precipitated with 2n5 vol. ethanol which contained 0n3 M sodium acetate (pH 4n8), separated on 1 % agarose gels by electrophoresis, and then autoradiographed.
PCR and Southern hybridization. In addition to using an endogenous DNA polymerase assay to analyse HBV nucleic acids in secreted viral particles, Dane-like particles collected from CsCl density gradients were subjected to PCR amplification followed by Southern hybridization. Particles were first digested with DNase (10 U) in a DNA buffer (10 mM Tris-HCl, pH 8n3, 50 mM KCl and 1n5 mM MgCl # ) at 37 mC for 1 h and then disrupted by boiling for 10 min (Bottcher et al., 1998) . Viral DNAs were amplified by PCR using the forward primer C401F (5h ATGGACATCGACCCTTATAAAG 3h) and the reverse primer S1764R (5h TGTTCCTGAACTGGAGCCACCAGCA 3h) for 40 cycles of 96 mC for 1 min, 57 mC for 1 min and 74 mC for 20 s and an additional extension period at 72 mC for 5 min. The amplified DNA products were resolved by electrophoresis on 2 % agarose gel and subjected to Southern blot analysis (Southern, 1975 ) using a probe containing the 279 bp HBV BamHI\EcoRI fragment (see also Fig. 7 a) .
Results

Expression of HBV core proteins with an N-terminal extension in E. coli
In this study, pHisC183 was constructed for the expression of HBV core proteins with an N-terminal extension, designated HisC183. HisC183 has 23 extra amino acids at the N terminus, including a stretch of six histidine residues (Fig. 1 b) . Expression of HisC183 was examined in two different strains of E. coli, BL21(DE3) and JM109(DE3), by SDS-PAGE and Western blot analyses. The Coomassie brilliant blue-stained gel showed no extra band (Fig. 2 a, upper panel) ; however, numerous bands were detected by anti-core antibodies in Western blots (Fig.  2 a, lower panel) when plasmid-harbouring bacteria were treated with IPTG. Although a few core-positive bands were also detected in the same plasmid-harbouring bacteria without IPTG treatment, this was most likely due to leaky transcription of the T7 promoter. Nevertheless, the molecular mass of the highest and dominant band is as expected, suggesting that fusion core proteins were expressed and some of them were degraded into small fragments.
Mutant core with an N-terminal His-tag can self-assemble in E. coli Since HisC183 was expressed in E. coli and easily extracted, it was of great interest to know whether HisC183 could selfassemble into nucleocapsids spontaneously as previous reports have suggested (Pasek et al., 1979 ; Cohen & Richmond, 1982 ; Stahl et al., 1982) . Soluble lysates from bacteria expressing HisC183 were centrifuged through CsCl density gradients and each fraction was subjected to ELISA for the presence of HBV core antigen (HBcAg). Several fractions of cell lysates from IPTG-induced bacteria exhibited a positive signal for HBcAg, i.e. peaks at densities of 1n18-1n20 and 1n26-1n31 g\ml (Fig. 2 b) . This result strongly indicated that HisC183 could self-assemble into nucleocapsids. Electron microscopic examination of negatively stained samples from the CsCl density peak (fractions 5-8) further confirmed that the nucleocapsids indeed formed in E. coli (inset of Fig. 2 b) .
To clarify whether or not the His-tag of HisC183 is exposed at the surface of nucleocapsids, we used an affinity column to purify HisC183. Results of Ni# + -affinity binding resin showed a single band in a 15 % SDS-PAGE gel stained with Coomassie brilliant blue (Fig. 2 c) , indicating that the Histag of HisC183 was accessible by nickel resins. Protein concentration analyses revealed that this band comprised approximately 8n5 mg HisC183, which was recovered from the 800 ml overnight culture. However, HisC183 bound on nickel resins could be in monomeric, dimeric or particulate form. Electron microscopic examination revealed that at least some HisC183 proteins, if not all of them, retained the integrity of nucleocapsids as those separated by CsCl gradient (Fig. 2 d) .
Dimerization of HBV core proteins with an N-terminal extension in hepatoma cells
Since the core-like particles obtained from E. coli lack several features of nucleocapsids, e.g. encapsidation of viral Fig. 4 . Density gradient analysis of cytoplasm-and medium-derived nucleocapsids. HuH-7 cells were transfected with plasmids as indicated. Intracellular lysate (left column of graphs) and extracellular media containing particles treated with NP-40 (right column of graphs) were subjected to CsCl gradient density sedimentation. Twenty fractions (500 µl each) were collected and analysed for the presence of core protein by ELISA. Density (g/ml) of individual fractions is shown by a dotted line in each panel. Filled-in circles show the OD 490 in the ELISA of each fraction. pregenome and cellular kinases, pHBVHisC183 (Fig. 1 a, line 3) was constructed for expression of HisC183 in HuH-7 hepatoma cells. Another plasmid, pHBVFlagC183 (Fig. 1 a, line 4) , was also constructed for expression of FlagC183, which has 10 extra amino acid residues, including five negatively charged glutamic acid residues, at the N terminus of the core protein (see Fig. 1 b) . In addition to having a different tag sequence to pHBVC183, pHBVFlagC183 is driven by the cytomegalovirus (CMV) promoter to express FlagC183 and the HBV sequence within it lacks the polyadenlyation signal. To characterize and test the expression of the N-terminal extension mutants, pHBVHisC183 or pHBVFlagC183 were co-transfected with a core-negative plasmid (pHBV∆C ; Fig. 1 a, line 6) (Hui et al., 1999) into HuH-7 hepatoma cells. In addition, a full-length HBV-containing plasmid, pMH 3\3097 (Fig. 1 a, line 1) , cotransfected with a vector plasmid, pUC-MT (Fig. 1 a, line 7) , was used as a positive control. Western blot analyses showed that wild-type and two mutant cores were detected by anticore antibodies (Fig. 3 a) . Migration of wild-type C183, and mutants HisC183 and FlagC183 was as expected, i.e. molecular masses of 21n5, " 24 and " 22 kDa, respectively. With a Histag or Flag-epitope at the N terminus, HisC183 and FlagC183 could be recognized by anti-His or anti-Flag antibodies, respectively, while wild-type HisC183 could not (Fig. 3 a, αHis and αFlag panels). To test whether the His-tagging and Flagtagging could affect dimer formation of core proteins (Zheng et al., 1992 ; , samples were analysed under non-reducing conditions. Results showed that a dimer was present in the wild-type C183 as well as in HisC183 and FlagC183 (Fig. 3 b) , indicating that formation of intermolecular disulfide bonds was not inhibited by the extensions of amino acid residues located at the N terminus.
Self-assembly into nucleocapsids by mutant cores in hepatoma cells
To verify whether the HisC183 and FlagC183 proteins can self-assemble into core-like particles in HuH-7 cells as in E. coli, we performed CsCl gradient analyses. Both intracellular extracts and detergent-treated extracellular media from cells transfected with the two plasmids in various combinations (as described above) were subjected to CsCl banding and then to ELISA analysis for the presence of core proteins. For another positive control of wild-type core expression, plasmid Fig. 1 (a) . Locations of primers, C401F and S1764R, for PCR amplification are indicated by arrowheads. The BamHI/EcoRI fragment, indicated by arrows, was used as a probe for Southern hybridization. (b) HuH-7 cells were transfected with various plasmids as specified at the top of each graph. Extracellular media were precleared with anti-core antibodies and subjected to CsCl gradient density sedimentation. Twenty fractions (500 µl each) were collected and analysed for the presence of HBsAg and core protein by ELISA. The density (g/ml) of individual fractions is shown by dotted lines. Filled-in (HBcAg) and open (HBsAg) circles show the OD 490 in the ELISA of each fraction. Fractions were pooled into D, D and D tubes and subjected to PCR amplification. PCR products from tubes 1-12 were separated on a 1 % agarose gel and probed by the HBV fragment as indicted in (a). Lane numbers on the gel correspond to the tube numbers collected from the CsCl fractions. Lane 13 is the negative control for PCR. Arrows on the left of the gel indicate the expected sizes of fragments (1363 and 1046 bp, respectively). Numbers on the right are the DNA markers in bp.
pHBV∆PSX, in which the P, S and X genes are deleted and the C gene remains intact (Fig. 1 a, line 5) , was also used as a comparison. Results showed a similar profile of core protein distribution obtained from the transfection of wild-type C183 (Fig. 4 a) , mutants HisC183 (Fig. 4 b) and FlagC183 (Fig. 4 c) as well as from the co-transfection of pHBV∆C and pHBV∆PSX (Fig. 4 d) . The core proteins were present at the peak of 1n18-1n20 g\ml or at the peak of 1n25-1n30 g\ml, which correspond to the density of empty core particles (light core) and nucleic acid-containing particles (heavy core), respectively. These results suggest that the N-terminal fusion core proteins do not significantly disrupt the structure of an assembled particle in HuH-7 cells as observed in E. coli (Fig. 2 b) .
Fusion core proteins can be phosphorylated by in vitro kinase reaction
Protein kinase activity has been demonstrated inside the HBV nucleocapsid (Albin & Robinson, 1980 ; Gerlich et al., 1982) , which is an indicator of intact particles. In order to obtain more evidence concerning the integrity of nucleocapsids assembled by HisC183 and FlagC183, we performed an in vitro kinase assay for nucleocapsids. Nucleocapsids were collected using immunoprecipitation with anti-core antibodies from both intracellular extracts and extracellular (NP-40-treated) media. The results of the in vitro phosphorylation showed that not only the wild-type C183 but also the HisC183 and FlagC183 mutant core proteins can be phosphorylated in both intracellular nucleocapsids (Fig. 5, upper panel) and extracellular nucleocapsids (Fig. 5, lower panel) . However, no sign of phosphorylation occurred in the FlagC151 mutant, which lacks the C-terminal serine residues, although nucleocapsids can be formed by FlagC151 (Hui et al., 1999) . These data suggest that mutant core proteins with an N-terminal extension do not interfere with the kinase packaging into nucleocapsids and particles remain intact.
Intracellular mutant nucleocapsids retain DNA repairing activity
One prominent property of nucleocapsids is the formation of partially double-stranded HBV DNA from the encapsidated pregenome by reverse transcriptase\DNA polymerase. This feature can be demonstrated by an endogenous polymerase activity assay (HBV DNA gap fill-in assay), in which a specific length of HBV DNA is filled-in by isotope-labelled nucleotides and is shown by autoradiography. To characterize the integrity of nucleocapsids assembled by HisC183 and FlagC183, an endogenous polymerase activity assay was applied to the samples of complementation experiments as used in the CsCl gradient assay (Fig. 4 b, c) . A band of 3n0 kb HBV DNA, which is presumably derived from the pregenome transcribed by pHBV∆C, was present in intracellular extracts from both cotransfections with pHBVHisC183 or pHBVFlagC183, together with a core-negative plasmid (pHBV∆C) (Fig. 6 a, lanes 3 and  4) . As expected, two bands of 3n0 kb and 2n1 kb were observed in the co-transfection of pHBV∆PSX and pHBV∆C and a single band of 3n2 kb was seen in pMH 3\3097 and pUC-MT cotransfection (Fig. 6 a, lanes 1 and 2) . Although the signal was weaker in the sample of co-transfection with pHBVFlagC183 and pHBV∆C (lane 4), data support the notion that intracellular nucleocapsids formed by HisC183 and FlagC183 remain functional in reverse transcription of the pregenome.
Impairment of envelopment in mutant nucleocapsids to form virion-like particles
Since intracellular nucleocapsids assembled by mutant core proteins contain functional components, we were interested to know whether these intracellular nucleocapsids can still interact with surface antigens to form secretable virion-like particles. Because a small amount of naked nucleocapsids can be found in the media from transfected HuH-7 cells (Figs 4 and 5 ; Gerelsaikhan et al., 1996) , we performed immunoprecipitation twice using excess anti-core antibodies to eliminate extracellular nucleocapsids. The HBV DNA gap fill-in assay for those media precleared by anti-core antibodies showed no sign of isotope-labelled HBV DNA in co-transfections of pHBVHisC183 or pHBVFlagC183 with pHBV∆C ( Fig. 6 b,  lanes 3 and 4) . As expected, two bands of 3n0 kb and 2n1 kb and a single band of 3n2 kb were observed in the positive groups, respectively (Fig. 6 b, lanes 1 and 2) . The results suggest that intracellular nucleocapsids assembled by HisC183 and FlagC183 could not be enveloped to form mature virions.
To further confirm that the observation of envelopment impairment occurred in mutant nucleocapsids, a more sensitive assay was carried out. Cell culture media precleared by anticore antibodies as described above were fractionated by CsCl gradient centrifugation and divided into three tubes : D, lighter density than Dane particles ; D, equal density to Dane particles ; and D, heavier density than Dane particles. Each tube was subjected to PCR amplification followed by Southern blot analysis for detection of HBV DNA present in the fraction. ELISA analyses of CsCl fractions showed that no naked nucleocapsids were present in any preparations (Fig. 7 b) . PCR and Southern blot results showed two bands of 1363 bp and 1046 bp in the sample co-transfected with pHBV∆C and pHBV∆PSX and a single band of 1363 bp in the sample cotransfected with pMH 3\3097 and pUC-MT (Fig. 7 b) , indicating that they were indeed derived from Dane-like particles instead of nucleocapsids in media. Lighter bands present in both D and D tubes of positive control groups might result from the incomplete separation and the oversensitive detection by PCR amplification plus Southern hybridization. Consistent with the DNA repairing assay results, no PCR product was detected in the tubes of D, D and D from samples which were co-transfected with mutant core plasmids and pHBV∆C (Fig. 7 b, lanes 7-12) ; this strongly suggests that no detectable virion was secreted by these transfected cells. Taking together all results from this study, we conclude that HBV core mutants with an N-terminal extension, HisC183 and FlagC183, can form a functional nucleocapsid intracellularly but are incapable of forming a mature and secretable Dane-like particle.
Discussion
In order to elucidate the role of the N terminus of the HBV core protein in virion maturation, we constructed core mutants with an N-terminal extension to test their ability to assemble nucleocapsids. Using CsCl gradient separation and electron microscopy analyses, we demonstrated that HisC183 could form nucleocapsids in both prokaryotic and eukaryotic systems and that FlagC183 could do so in eukaryotic cells (Figs 2 and  4) . In addition, nucleocapsids assembled by HisC183 and FlagC183 in hepatoma cells retained a kinase activity and an endogenous polymerase activity ( Figs 5 and 6 a) . However, these particles could not form secretable virions (Figs 6 b and 7 b), suggesting that either the additional amino acids at the N terminus interfere directly with envelopment by surface antigens or block the signals for the process of envelopment.
In the past, HBV core proteins have been successfully used to express heterologous epitopes in many prokaryotic and eukaryotic systems because of their ability to form particles (see review by Pumpens & Grens, 1999) . In addition, HBV nucleocapsids are exceptionally potent antigens that induce both T-cell-dependent and T-cell-independent responses (see review by Schodel et al., 1996) . Several insertion sites have been tested to improve the immunogenicity of foreign peptides (Clarke et al., 1990 ; Pumpens et al., 1995 ; Borisova et al., 1996 ; Ulrich et al., 1998) . Three insertions, located at aa 1-3, 74-93 and 141-183 of core proteins, are found to be regions that are dispensable for nucleocapsid assembly (Pumpens & Grens, 1999) . In this study, the nucleocapsid assembled by HisC183 is consistent with previous studies and gives a new example that additional amino acids at the N terminus do not disturb formation of the nucleocapsid. Furthermore, it shows that the His-tag of HisC183 is possibly located at the surface of nucleocapsids, since the particles can be purified on a nickel column (Fig. 2 c and d) . It is noted that three bands of HisC183 were observed on the Western blot as compared with one single band of purified HisC183 on the gel stained by Coomassie brilliant blue (Fig. 2 a, lane 8 vs c, lane 2) . This could be because (i) the HisC183 protein inside the bacteria is not completely reduced by DTT while the purified HisC183 is fully reduced, or (ii) degradation of HisC183 occurs inside bacteria while those degraded forms cannot be recovered from the nickel column.
In addition to demonstrating that nucleocapsids are assembled from HisC183 in E. coli, we also showed that nucleocapsids are able to assemble using HisC183 in human hepatoma cells and that they retained kinase and DNA polymerase activities. To date, the role of cellular kinase encapsidated by HBV core particles remains poorly defined. Our current finding provides evidence that the N-terminal additions to the core protein do not interfere in cellular kinase incorporation. Although we did not produce FlagC183 in E. coli to test for nucleocapsid formation, we showed that FlagC183 has all the characteristics of HisC183 in hepatoma cells. Basically, the additional amino acids present in HisC183 or FlagC183 do not disrupt the formation of core dimer, which provides grounds for further polymerization to form particles . If the intermolecular Cys-61-Cys-61 disulfide bond of core proteins is disrupted, no particles are produced (Conway et al., 1998 b) .
In this study, we provide additional information on the envelopment of mutant nucleocapsids, since envelopment is one of the critical steps in HBV maturation. Three surface proteins (L-HBsAg, M-HBsAg and S-HBsAg) on the envelope are important for virus maturation and infection (Ueda et al., 1991 ; Bruss & Ganem, 1991 ; Le Seyec et al., 1998) . The molecular nature of the HBV envelopment signal is still unknown. However, previous reports have suggested that triggering the envelopment signal is linked to genomic replication in the interior of nucleocapsids (Gerelsaikhan et al., 1996 ; Wei et al., 1996) . Such a signal may result in a conformational change in the core proteins and allow interaction between the core proteins and surface proteins to occur. Bottcher et al. (1998) have demonstrated that L-HBsAg may bind to Glu-77 and Asp-78 of the core protein. Therefore, the impairment of envelopment in nucleocapsids assembled from HisC183 and FlagC183 (Fig. 7) is possibly influenced by the six histidines or the five glutamic acids at the N terminus of the core protein (Fig. 1 b) . These N-terminal extensions could either block the envelopment signal or interfere with surface antigen binding to core particles. Based on results of the accessibility of the His-tag and Flag-tag by antibodies (data not shown) or nickel resins (Fig. 2 c, d) , we favour the second hypothesis. Nevertheless, further cryoelectron microscopy is required to reveal the structure of HisC183 particles isolated from E. coli, which are easily obtained from the pHisC183-harbouring cells. The structure of HisC183 particles will definitely provide a better conclusion.
